NCT02045888View on ClinicalTrials.gov

Safety and Feasibility of ADRCs (Adipose Derived Regenerative Cells) in Patients With Grade II Hamstring Tears

PHASE1/PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

January 31, 2014

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Muscle Tear
Interventions
DEVICE

ADRCs prepared by investigational Celution Device

ADRCs (low dose and high dose) to be used in investigational treatment will be prepared using the investigational Celution Device which is being investigated under IDE 15363

BIOLOGICAL

Placebo

Placebo is visually matched solution

Trial Locations (2)

77030

Houston

90045

Los Angeles

Sponsors
All Listed Sponsors
lead

Cytori Therapeutics

INDUSTRY